HomeNewsBusinessStartupExclusive | Oyo lays off another 600-800 employees as it moves to a revenue-sharing model

Exclusive | Oyo lays off another 600-800 employees as it moves to a revenue-sharing model

Until early this year, the company had around 10,000 employees in the country. Now, the number is estimated to have come down to less than 2,500, with Oyo shifting to a lean model and exiting operations and renovations.

December 08, 2020 / 16:14 IST
Story continues below Advertisement

With the aim of reducing costs further, Softbank-backed hospitality firm Oyo has again laid off around 600-800 employees, according to sources privy to the development. Most of the staffers are from the renovation and operations departments. The company plans to shut down these divisions and focus primarily on a revenue-sharing model with partner hotels.

Oyo will now be charging the hotel partners a share of the entire revenue they earn on their properties. It will cease to offer a minimum guarantee or even provide management staff at the hotel premises, something it used to do with the aim of maintaining consistency and to monitor quality.

Story continues below Advertisement

Now, while the hotel owners will be responsible for operations, the marketing will be done by Oyo.

Besides, regular compensation, which includes notice pay and leave encashment, the company is also offering these employees an option to surrender 25 percent of the unvested deeply discounted ESOPs granted to them in June in lieu of a cash benefit. This cash amount can be equal to 25 percent of their March 2020 fixed salary.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show